Innoviva, Inc. INVA
20.93 USD -0.09 (-0.43%)
At closeNov 3, 2026, 4:01 PM EST
20.93 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
20.90 Day range 21.39
17.87 52-week range 25.15
- YTD
- +4.70%
- 1 year
- +15.57%
Analyst view
Price target (mean) 35.00 +67.2% upside
Now 20.93
- Target (low)
- 18.00
- Target (mean)
- 35.00
- Target (high)
- 46.00
Ratings (0m) 5 4 buy · 0 hold · 1 sell
- Strong buy0
- Buy4
- Hold0
- Sell1
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.34 | -0.36 – 0.57 | 1.08 | -68.5% | 115.31M | +7.0% | 5 |
| Next quarter | 0.522 | 0.46 – 0.61 | 1.94 | -73.1% | 118.42M | +3.3% | 5 |
| Current year | 2.23 | 1.49 – 2.56 | 3.30 | -32.3% | 451.29M | +9.7% | 5 |
| Next year | 2.26 | 1.92 – 2.83 | 2.23 | +1.3% | 490.01M | +8.6% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jun 22, 2026 | BTIG | Maintained | Buy | Buy |
| Jun 1, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 26, 2026 | BTIG | Reiterated | Buy | Buy |
| May 7, 2026 | BTIG | Maintained | Buy | Buy |
| Feb 26, 2026 | BTIG | Reiterated | Buy | Buy |
| Feb 17, 2026 | BTIG | Initiated | — | Buy |
| Dec 16, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 6, 2025 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Sep 30, 2025 | Goldman Sachs | Initiated | — | Sell |
| Aug 11, 2025 | Oppenheimer | Initiated | — | Outperform |
| Aug 11, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 14, 2025 | HC Wainwright & Co. | Initiated | — | Buy |
| Jul 11, 2025 | Cantor Fitzgerald | Initiated | — | Overweight |
| Mar 7, 2025 | Scotiabank | Initiated | — | Sector Outperform |
| Aug 1, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Jul 30, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Jun 20, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Jun 18, 2024 | Cantor Fitzgerald | Initiated | — | Overweight |
| May 10, 2023 | EF Hutton | Reiterated | — | Buy |
| Apr 20, 2023 | EF Hutton | Reiterated | — | Buy |
| Mar 3, 2023 | Goldman Sachs | Maintained | — | Neutral |
| Mar 3, 2023 | Morgan Stanley | Maintained | — | Underweight |
| Mar 3, 2023 | EF Hutton | Reiterated | — | Buy |
| Jan 24, 2023 | Morgan Stanley | Maintained | — | Underweight |
| Oct 13, 2022 | Morgan Stanley | Maintained | — | Underweight |
| Aug 8, 2022 | Morgan Stanley | Maintained | — | Underweight |
| Jul 20, 2022 | Goldman Sachs | Initiated | — | Neutral |
| Jul 15, 2022 | Morgan Stanley | Maintained | — | Underweight |
| Apr 12, 2022 | Morgan Stanley | Maintained | — | Underweight |